Oceania · General news · The Advertiser (Adelaide Now)
Dr Boreham’s Crucible: Identifai brings a bigger genetic net to pre-natal screening
On Tuesday last week, Tel Aviv’s genetic screening innovator Identifai Genetics (ASX:ID1) joined the ASX after raising $10 million in a rare local biotech initial public offer.
Read the full article on The Advertiser (Adelaide Now) Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.adelaidenow.com.au)


